Akero Therapeutics News

Akero Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

May 10 16:00

Akero Therapeutics | 10-Q: Quarterly report

May 10 06:34

Akero Therapeutics | 8-K: Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

May 10 06:19

Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Young Jonathan

May 2 20:10

Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gangloff Scott A.

May 1 18:37

Akero Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Gangloff Scott A.

May 1 18:37

Akero Therapeutics | ARS: Annual Report to Security Holders

Apr 26 15:45

Akero Therapeutics | DEF 14A: Definitive information statements

Apr 26 15:37

Akero Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 16 15:31

Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Young Jonathan

Apr 3 17:59

Akero Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 1 15:23

Akero Therapeutics | 8-K: Current report

Mar 18 15:36

Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yale Catriona

Mar 15 15:52

Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer White William Richard

Mar 15 15:51

Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cheng Andrew

Mar 15 15:51

Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rolph Timothy

Mar 15 15:47

Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Young Jonathan

Mar 15 15:47

Akero Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-General Atlantic, L.P.(7.7%),General Atlantic Partners 100, L.P.(7.7%), etc.

Mar 15 09:10

Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cheng Andrew

Mar 6 19:15

Akero Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yale Catriona

Mar 6 19:15